COVID-19

Views & Analysis

Towards a new understanding of cardiovascular risk in diabetes

Is cardiovascular disease a ‘pandemic hiding in plain sight’...

Amarin’s Craig Granowitz discusses the impact of COVID on cardiovascular disease treatment and explains why there’s still a long way to go till we can truly tackle these diseases.<

News

FDA gives Roche's Actemra emergency okay for severe COVID

Roche has been granted emergency approval by the FDA for its arthritis drug Actemra as a treatment for patients aged two or over who are hospitalised with severe COVOD-19 symptoms.

Views & Analysis

Digital strategies for pharma’s physician engagement

Pharmaceutical sales and marketing operations have been forced to follow a steep learning curve as they adjust to operating within the rapidly evolving and hugely changed landscape caused b

News

UK trial will see if data trumps hype over ivermectin's role...

Despite limited data, anti-parasitic drug ivermectin has become widely used in some areas of the world as a treatment for COVID-19.

News

Pair of R&D updates bolster GSK ahead of investor meeting

GlaxoSmithKline (GSK) has reported encouraging data for its COVID-19 antibody sotrovimab, and an alliance with Halozyme to develop a new generation of long-acting HIV drugs, as it prepares

News

US aims $80m of its rescue plan funding at public health IT

President Joe Biden's $3 billion pandemic rescue package includes $80 million in funding for to strengthen the US's public health IT and data science capabilities.

Is cardiovascular disease a ‘pandemic hiding in plain sight’...

FDA gives Roche's Actemra emergency okay for severe COVID

Digital strategies for pharma’s physician engagement

UK trial will see if data trumps hype over ivermectin's role...

Pair of R&D updates bolster GSK ahead of investor meeting

US aims $80m of its rescue plan funding at public health IT

The long-delayed promise of the microbiome, with Sam Possemi...

How to meet your physicians where they are online

COVID-19

Editor's Picks